Embraced with apolipoproteins (Apo) B and Apo E, triglyceride-enriched very-low-density
lipoprotein (VLDL) is secreted by the liver into circulation, mainly during post-meal hours …

Abstract Background and Aims Lipoprotein (a)(Lp [a]) is an established risk factor for
atherosclerotic cardiovascular disease (ASCVD). However, data on association of Lp (a) …

Background The role of aspirin in reducing lipoprotein (a)-mediated atherothrombotic events
in primary prevention is not established. Objectives This study sought to assess whether low …

Modern anticoagulation therapy has dramatically reduced the risk of stroke and systemic
thromboembolism in people with atrial fibrillation (AF). However, AF still impairs quality of …

Cardiovascular disease (CVD) is still a leading cause of morbidity and mortality, despite all
the progress achieved as regards to both prevention and treatment. Having high levels of …

Lipids are primarily transported in the bloodstream by lipoproteins, which are
macromolecules of lipids and conjugated proteins also known as apolipoproteins. The …

This study aimed to investigate whether there was a difference in one-year outcome after
stroke between patients treated with antiplatelet and anticoagulation (OAC+ antiplatelet) and …

Low-density lipoprotein (LDL) levels are utilized in the assessment of an individual's
cardiovascular disease risk and serve as a valuable tool in the determination of appropriate …

Atrial fibrillation (AF) is one of the most common arrhythmias in adults, and its continued rise
in the United States is complicated by the increased incidence and prevalence of several AF …

Highlights What are the main finding? Higher serum levels of total cholesterol and low-
density lipoprotein cholesterol are associated with the severity of AP, while the persistent …